Neuropathologic characterization of a canine model of mucopolysaccharidosis IIIB and additional studies in anti-inflammatory therapy and neuroinflammatory kinetics
Author(s) -
Tyler A. Harm
Publication year - 2021
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.31274/etd-20210609-65
Subject(s) - mucopolysaccharidosis , enzyme replacement therapy , glycosaminoglycan , mucopolysaccharidosis type i , heparan sulfate , lysosomal storage disease , pathology , mucopolysaccharidosis i , medicine , gliosis , genetic enhancement , spinal cord , pathogenesis , substrate reduction therapy , immunology , chemistry , biochemistry , gene , disease , anatomy , psychiatry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom